Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07492004

China Monogenic Diabetes Registry

Status
Recruiting
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
Tianjin Medical University General Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This observational study aims to establish a digital registry, screening platform for patients with monogenic diabetes using internet-based and mobile application technologies. The primary objectives are to: Characterize the genetic landscape of monogenic diabetes in the Chinese population, including pathogenic variants and their distribution Participants will: * Enroll in the monogenic diabetes registry via mobile application or web-based platform * Undergo molecular genetic testing to establish a definitive diagnosis

Detailed description

This study will include the subjects of a series of studies on monogenic diabetes conducted by our team, including neonatal diabetes, maturity-onset diabetes of the young, maternally inherited diabetes and deafness, and other monogenic diabetes caused by different causative genes, and establish a large sample database and specimen bank through follow-up and omics analysis.

Conditions

Interventions

TypeNameDescription
OTHERNo InterventionsNo Interventions

Timeline

Start date
2021-02-28
Primary completion
2030-07-31
Completion
2030-07-31
First posted
2026-03-25
Last updated
2026-03-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07492004. Inclusion in this directory is not an endorsement.